{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:27:47Z","timestamp":1780446467772,"version":"3.54.1"},"reference-count":44,"publisher":"Georg Thieme Verlag KG","issue":"06","license":[{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Background and Purpose\u2003Oral anticoagulants (OACs) prevent stroke recurrence and vascular embolism in patients with acute ischemic stroke (AIS) and atrial fibrillation (AF). Based on empirical consensus, current guidance recommends a \u201c1\u20133\u20136\u201312 days\u201d rule to resume OACs after AIS. This study investigated the suitability of guideline-recommended timing for OAC initiation.<\/jats:p><jats:p>Methods\u2003Using data of 12,307 AF patients hospitalized for AIS, for the period 2012 to 2016, in Taiwan's National Health Insurance Research Database, we constructed a sequence of cohorts of OAC users and propensity score-matched nonusers, creating one cohort on each day of OAC initiation for 30 days since admission. Composite outcome included effectiveness (cardiovascular death, ischemic stroke, myocardial infarction, transient ischemic attack, systemic embolism, and venous thromboembolism) and safety (intracranial hemorrhage, gastrointestinal bleeding, and hematuria) outcomes. Comparing with nonusers, we examined the risks in the early OAC use (within 1\u20133\u20136\u201312 days) or guideline-recommended delayed use. Indirect comparison between the early and delayed use was conducted using mixed treatment comparison.<\/jats:p><jats:p>Results\u2003Across the AIS severity, the risks of composite or effectiveness outcome were lower in OAC users than nonusers, and the risks were similar between the early and delayed use groups. In patients with severe AIS, early OAC use was associated with an increased risk of safety outcome, with a hazard ratio (HR) of 1.67 (confidence interval [CI]: 1\u00b730\u20132\u00b713) compared with nonusers and a HR of 1.44 (CI: 0\u00b799\u20132\u00b709) compared with the delayed use.<\/jats:p><jats:p>Conclusion\u2003Our study findings support an early OAC initiation in AF patients with mild-to-moderate AIS and a routine delayed use of OACs can be considered in those with severe AIS to avoid a serious bleeding event.<\/jats:p>","DOI":"10.1055\/a-1669-4987","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T22:58:49Z","timestamp":1634252329000},"page":"939-950","source":"Crossref","is-referenced-by-count":18,"title":["Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation"],"prefix":"10.1055","volume":"122","author":[{"given":"Po-Yin","family":"Chang","sequence":"first","affiliation":[{"name":"Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Maryland, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2064-9523","authenticated-orcid":false,"given":"Wei-Ting","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan"},{"name":"Department of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Tsai","sequence":"first","affiliation":[{"name":"Institute of Health and Welfare Policy, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3885-6600","authenticated-orcid":false,"given":"Hao-Min","family":"Cheng","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan"},{"name":"Department of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Center for Evidence-based Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Lun","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Health and Welfare Policy, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chin","family":"Chang","sequence":"additional","affiliation":[{"name":"Institute of Health and Welfare Policy, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Huan","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Department of Medical Education, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Institute of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hwa","family":"Chiou","sequence":"additional","affiliation":[{"name":"Department of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom"},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chern-En","family":"Chiang","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan"},{"name":"General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,12,31]]},"reference":[{"issue":"05","key":"ref1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"GBD 2016 Stroke Collaborators","year":"2019","journal-title":"Lancet Neurol"},{"issue":"08","key":"ref2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"P A Wolf","year":"1991","journal-title":"Stroke"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons","volume":"140","author":"C T January","year":"2019","journal-title":"Circulation"},{"issue":"16","key":"ref4","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"J Steffel","year":"2018","journal-title":"Eur Heart J"},{"issue":"22","key":"ref5","doi-asserted-by":"crossref","first-page":"e010133","DOI":"10.1161\/JAHA.118.010133","article-title":"Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: time to initiation of oral anticoagulant therapy and outcomes","volume":"7","author":"M Paciaroni","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"38","key":"ref6","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"P Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1474-4422(18)30145-5","article-title":"Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2): a multicentre observational cohort study","volume":"17","author":"D Wilson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"08","key":"ref8","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/STROKEAHA.115.008891","article-title":"Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study","volume":"46","author":"M Paciaroni","year":"2015","journal-title":"Stroke"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"e007034","DOI":"10.1161\/JAHA.117.007034","article-title":"Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with non-vitamin-K oral anticoagulants (RAF-NOACs) study","volume":"6","author":"M Paciaroni","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1253\/circj.CJ-18-0067","article-title":"Two-year outcomes of anticoagulation for acute ischemic stroke with nonvalvular atrial fibrillation - SAMURAI-NVAF study","volume":"82","author":"S Yoshimura","year":"2018","journal-title":"Circ J"},{"issue":"18","key":"ref11","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1212\/WNL.0000000000003283","article-title":"Early start of DOAC after ischemic stroke: risk of intracranial hemorrhage and recurrent events","volume":"87","author":"D J Seiffge","year":"2016","journal-title":"Neurology"},{"issue":"09","key":"ref12","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.06.031","article-title":"Early initiation of anticoagulation with direct oral anticoagulants in patients after transient ischemic attack or ischemic stroke","volume":"25","author":"K Macha","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11239-016-1393-9","article-title":"Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation","volume":"42","author":"M Cappellari","year":"2016","journal-title":"J Thromb Thrombolysis"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ana.25489","article-title":"Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation","volume":"85","author":"D J Seiffge","year":"2019","journal-title":"Ann Neurol"},{"issue":"03","key":"ref15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1161\/STROKEAHA.119.028118","article-title":"Early initiation of direct oral anticoagulants after onset of stroke and short- and long-term outcomes of patients with nonvalvular atrial fibrillation","volume":"51","author":"T Mizoguchi","year":"2020","journal-title":"Stroke"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/STROKEAHA.115.011476","article-title":"Cardiovascular, bleeding, and mortality risks of dabigatran in asians with nonvalvular atrial fibrillation","volume":"47","author":"Y-H Chan","year":"2016","journal-title":"Stroke"},{"issue":"16","key":"ref17","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jacc.2014.06.1203","article-title":"Using the CHA2DS2-VASc score for refining stroke risk stratification in \u2018low-risk\u2019 Asian patients with atrial fibrillation","volume":"64","author":"T F Chao","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"07","key":"ref18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.11.046","article-title":"Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?","volume":"65","author":"T F Chao","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2015.07.026","article-title":"Age threshold for increased stroke risk among patients with atrial fibrillation: a nationwide cohort study from Taiwan","volume":"66","author":"T F Chao","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"ref20","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1161\/CIRCULATIONAHA.114.013709","article-title":"Rate-control treatment and mortality in atrial fibrillation","volume":"132","author":"T-F Chao","year":"2015","journal-title":"Circulation"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan","volume":"20","author":"C L Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"03","key":"ref22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jfma.2013.09.009","article-title":"Validating the diagnosis of acute ischemic stroke in a National Health Insurance claims database","volume":"114","author":"C Y Hsieh","year":"2015","journal-title":"J Formos Med Assoc"},{"issue":"09","key":"ref23","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.clinthera.2008.09.010","article-title":"Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation\u2013a nationwide descriptive study in Taiwan","volume":"30","author":"L J Lin","year":"2008","journal-title":"Clin Ther"},{"issue":"01","key":"ref24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.atherosclerosis.2013.11.036","article-title":"Continuation of statin therapy and a decreased risk of atrial fibrillation\/flutter in patients with and without chronic kidney disease","volume":"232","author":"C-H Chang","year":"2014","journal-title":"Atherosclerosis"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1186\/s12913-016-1769-8","article-title":"Validity of a stroke severity index for administrative claims data research: a retrospective cohort study","volume":"16","author":"S F Sung","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"04","key":"ref26","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/pds.3944","article-title":"A comparison of stroke severity proxy measures for claims data research: a population-based cohort study","volume":"25","author":"S-F Sung","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jclinepi.2015.01.009","article-title":"Developing a stroke severity index based on administrative data was feasible using data mining techniques","volume":"68","author":"S-F Sung","year":"2015","journal-title":"J Clin Epidemiol"},{"issue":"09","key":"ref28","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/apt.12483","article-title":"Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study","volume":"38","author":"C C Lin","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"S Suissa","year":"2008","journal-title":"Am J Epidemiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2016.04.014","article-title":"Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses","volume":"79","author":"M A Hern\u00e1n","year":"2016","journal-title":"J Clin Epidemiol"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","article-title":"Constructing a control group using multivariate matched sampling methods that incorporate the propensity score","volume":"39","author":"P R Rosenbaum","year":"1985","journal-title":"Am Stat"},{"issue":"06","key":"ref32","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/EDE.0b013e3181875e61","article-title":"Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease","volume":"19","author":"M A Hern\u00e1n","year":"2008","journal-title":"Epidemiology"},{"issue":"446","key":"ref33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"J P Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"06","key":"ref34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"P C Austin","year":"2016","journal-title":"Circulation"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/bimj.201600125","article-title":"Metaanalysis with R. G.Schwarzer, J. R.Carpenter, G.R\u00fccker (2015). Berlin, DE: Springer. ISBN: 978\u20133-319\u201321415\u20133","volume":"59","author":"A Hoyer","year":"2017","journal-title":"Biom J"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7326\/0003-4819-151-5-200909010-00003","article-title":"The net clinical benefit of warfarin anticoagulation in atrial fibrillation","volume":"151","author":"D E Singer","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10","key":"ref37","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/STROKEAHA.116.013880","article-title":"Validation of a modified CHA2DS2-VASc score for stroke risk stratification in asian patients with atrial fibrillation: a nationwide cohort study","volume":"47","author":"T F Chao","year":"2016","journal-title":"Stroke"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"50","author":"W J Powers","year":"2019","journal-title":"Stroke"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.7861\/clinmedicine.17-2-154","article-title":"The latest national clinical guideline for stroke","volume":"17","author":"A G Rudd","year":"2017","journal-title":"Clin Med (Lond)"},{"issue":"S 01","key":"ref40","first-page":"A119","article-title":"Abstract 119: initiating oral anticoagulation 4 to 14 days after a cardioembolic stroke is not associated with a reduction in ischemic or hemorrhagic events: the IAC Multicenter cohort","volume":"51","author":"S Yaghi","year":"2020","journal-title":"Stroke"},{"issue":"03","key":"ref41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp-2018-318890","article-title":"Early versus late anticoagulation for ischaemic stroke associated with atrial fibrillation: multicentre cohort study","volume":"90","author":"D Wilson","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/jamaneurol.2017.2161","article-title":"Rivaroxaban vs warfarin sodium in the ultra-early period after atrial fibrillation\u2013related mild ischemic stroke: a randomized clinical trial","volume":"74","author":"K-S Hong","year":"2017","journal-title":"JAMA Neurol"},{"issue":"18","key":"ref43","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/1747493017711947","article-title":"Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II)","volume":"12","author":"K H Ng","year":"2017","journal-title":"Int J Stroke"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"e2017047","DOI":"10.4178\/epih.e2017047","article-title":"Network meta-analysis: application and practice using Stata","volume":"39","author":"S Shim","year":"2017","journal-title":"Epidemiol Health"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1669-4987.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T23:44:12Z","timestamp":1725925452000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1669-4987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,14]]},"references-count":44,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2022,7,4]]},"published-print":{"date-parts":[[2022,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1669-4987","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,14]]},"published":{"date-parts":[[2021,10,14]]}}}